TECH · Healthcare

BIO-TECHNE Corp

Ranked earnings events from SEC filings, earnings calls, press releases and news. Full Picture: what to focus on this earnings window

News · 2026-08-07

Acquisition / Partnership / DivestitureImportance 65 · Surprise 60
Bio-Techne recently agreed to be acquired by Merck KGaA. The proposed transaction is expected to strengthen Merck’s position in high-growth life science markets. The deal was cited alongside Merck’s increased 2026…
Market Demand TrendsImportance 22 · Surprise 32
The global research-use-only recombinant protein market is projected to grow from $1.11 billion in 2026 to $1.55 billion by 2031, representing a 7.0% CAGR. Demand is being driven by expanding drug discovery,…

Acquisition / Partnership / DivestitureImportance 65 · Surprise 60
Bio-Techne recently agreed to be acquired by Merck KGaA. The proposed transaction is expected to strengthen Merck’s position in high-growth life science markets. The deal was cited alongside Merck’s increased 2026…
Market Demand TrendsImportance 22 · Surprise 32
The global research-use-only recombinant protein market is projected to grow from $1.11 billion in 2026 to $1.55 billion by 2031, representing a 7.0% CAGR. Demand is being driven by expanding drug discovery,…
Revenue Performance and MixImportance 18 · Surprise 14
Bio-Techne reported first-quarter revenue of $311.42 million, down 1.5% year over year. First-quarter EPS was $0.53, below the $0.55 analyst consensus estimate. The reported results indicate modest year-over-year…

Acquisition / Partnership / DivestitureImportance 65 · Surprise 60
Bio-Techne recently agreed to be acquired by Merck KGaA. The proposed transaction is expected to strengthen Merck’s position in high-growth life science markets. The deal was cited alongside Merck’s increased 2026…
Market Demand TrendsImportance 22 · Surprise 32
The global research-use-only recombinant protein market is projected to grow from $1.11 billion in 2026 to $1.55 billion by 2031, representing a 7.0% CAGR. Demand is being driven by expanding drug discovery,…